ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0151

Usefulness of Ultrasound and (FDG) PET/CT to Detect Cranial and Extracranial Artery Involvement in Patients with Suspected Large Vessel Vasculitis

Juan Molina1, Isabel Castrejón2, Javier Rivera2, Julia Martínez Barrio2, Juan Carlos Nieto2, Katerine López2, Fernando Montero2, Laura Trives Folguera2, Carlos González3 and Jose Maria Alvaro-Gracia2, 1Hospital General Universitario Gregorio Maran, Madrid, Spain, 2Hospital General Universitario Gregorio Marañón, Madrid, Spain, 3CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Meeting: ACR Convergence 2021

Keywords: giant cell arteritis, Imaging, Takayasu.s arteritis, Ultrasound, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Imaging of Rheumatic Diseases Poster (0149–0182)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Ultrasound (US) is recommended as the first imaging modality to assess patients presenting with predominantly cranial symptoms of giant cell arteritis (GCA). However, its value in assessing extra-cranial involvement remains unclear, being the 8F-fluorodeoxyglucose (FDG) PET/CT the ancillary study recommended. We aim to compare US versus FDG PET/CT to detect cranial and extra-cranial artery involvement in patients with suspected large vessel vasculitis (LVV).

Methods: Retrospective observational study including patients referred to a GCA fast track pathway (FTP) over a 2-years period. All patients underwent US exam of temporal (TA) and large vessel (LV) (carotid, subclavian and axillary) arteries within 24 hours of referral per protocol. Positive US findings were defined as a halo and/or compression sign in TA and a halo and/or intima media thickness >1mm in LV arteries. FDG PET/CT was performed per clinician criteria and was defined as positive if an artery FDG uptake was higher than liver uptake. The qualitative FDG uptake in the aorta, its aortic branches (carotid, axillary and subclavian), iliac and cranial arteries was also registered. All US exams were made before the FDG PET/CT evaluation. The external criterion for US and FDG PET/CT comparison was LVV clinical confirmation after 6 months follow-up.

Results: A total of 113 patients were included, 74.3% female with mean age 74 (11) years. After 6 months of follow-up, 37 (32.7%) patients had LVV clinical confirmation (34 GCA and 3 Takayasu). Only 3 (3.9%) patients without LVV versus 32 (86.5%) with LVV had positive US findings (Table 1). Among patients with LVV, 24 (64.9%) had TA involvement and 16 (43.2%) had extra-cranial LVV according to US examination (37.8% axillary, 29.7% subclavian and 32.4% carotid artery involvement). We found a mixed pattern with involvement of both TA and LV arteries in 8 (21.6%) patients. Overall, sensitivity and specificity of US for LVV was 86.5% and 96.1%, respectively, and for exclusively LV involvement was 94.1% and 80.2 %, respectively. A total of 28 patients underwent a FDG-PET/CT, of whom 12 (42.9%) showed positive findings. Taking FDG-PET/CT as the reference, US showed positive extracranial findings in 10 (83.3%) of those 12 patients and was able to detect 2 (12.5%) additional cases of large vessel involvement with negative FDG-PET/CT examination (Table 2). On the other hand, FDG-PET/CT showed LV artery involvement in 2 patients with negative US findings (1 patient with isolated aortitis and 1 patient with aorta and iliac artery involvement) (Table 3). FDG-PET/CT showed cranial arteries uptake in none of patients.

Conclusion: US is comparable to FDG-PET/CT for LVV diagnosis. Although presence of US extra-cranial artery inflammation is consistent with FDG-PET/CT examination, a negative US scan does not rule out extracranial involvement. FDG-PET/CT is of limited value for assessing cranial arteries. Thus, US may be used as the first line investigation not only in suspected cranial, but also extracranial LVV.

Table 1. Clinical, laboratory and imaging findings of patients included in the fast track pathway with and without LVV. LVV: large vessel vasculitis; PMR: polymyalgia rheumatica; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; US: ultrasound; SD: standard deviation

Table 2. Ultrasound findings of patients included in the fast-track pathway taking FDG-PET/CT as the reference for large vessel vasculitis. LVV: large vessel vasculitis; US: ultrasound

Table 3. Comparison between US and PET/CT findings in patients with PET/TC proven LVV. TA: temporal artery; CA: carotid artery; AA: axillary artery; SA: subclavian artery, IA: iliac artery


Disclosures: J. Molina, None; I. Castrejón, None; J. Rivera, None; J. Martínez Barrio, None; J. Nieto, None; K. López, None; F. Montero, None; L. Trives Folguera, None; C. González, None; J. Alvaro-Gracia, None.

To cite this abstract in AMA style:

Molina J, Castrejón I, Rivera J, Martínez Barrio J, Nieto J, López K, Montero F, Trives Folguera L, González C, Alvaro-Gracia J. Usefulness of Ultrasound and (FDG) PET/CT to Detect Cranial and Extracranial Artery Involvement in Patients with Suspected Large Vessel Vasculitis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/usefulness-of-ultrasound-and-fdg-pet-ct-to-detect-cranial-and-extracranial-artery-involvement-in-patients-with-suspected-large-vessel-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/usefulness-of-ultrasound-and-fdg-pet-ct-to-detect-cranial-and-extracranial-artery-involvement-in-patients-with-suspected-large-vessel-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology